Emblem Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Emblem Corp. - overview
Established
2015
Location
Toronto, ON, Canada
Primary Industry
Healthcare
About
Emblem Corp. is a Canadian company focused on the production and distribution of medical cannabis products, offering innovative solutions tailored for patient care and symptom management. Founded in 2015 by Maxim Zavet in Toronto, Canada, Emblem Corp. is engaged in the medical cannabis sector.
The company underwent a significant pivot in its strategy when it was acquired by Aleafia Health Inc. in March 2019 for CAD 173. 2 million, following a deal on December 19, 2018. Maxim Zavet, the founder, is noted for his entrepreneurial background, although there are no additional details on previous ventures available.
Emblem Cannabis specializes in high-quality medical cannabis products and patient services designed to enhance the medical cannabis experience for registered patients. Their offerings include full-spectrum, odorless extracts and hand-cultivated dried flower products, which are aimed at addressing various medical needs such as pain management. The company primarily serves the Canadian market through an online marketplace and partnerships with healthcare providers, facilitating access for individual patients and their practitioners. In 2018, Emblem Corp.
reported a revenue of CAD 3,323,900 and an EBITDA of CAD -7,575,400. Revenue is generated through direct-to-consumer sales of medical cannabis products via an online registration and purchasing model, which ensures a streamlined process for patients with medical authorization to access their desired products. Emblem Corp. plans to leverage its recent acquisition to enhance its market presence and product offerings.
The company aims to expand its product line with new therapeutic cannabis solutions, targeting a broader patient demographic. With the strategic funding from Aleafia Health Inc. , Emblem Corp. will also focus on entering new geographic markets beyond Canada, although specific regions and deadlines for these expansions have not been disclosed.
The latest funding round will support the development of these initiatives, ensuring the company is well-positioned for future growth.
Current Investors
Aleafia Health Inc.
Primary Industry
Healthcare
Sub Industries
Alternative Medicine, Pharmaceuticals
Website
www.emblemcorp.com
Verticals
Cannabis/Medical Marijuana
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Emblem Corp. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Emblem Corp. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.